{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10(2)"],"submitter":["Zapata-Canto N"],"pubmed_abstract":["Background
The present retrospective study reviewed acute promyelocytic leukemia (APL) cases recorded in Mexico between January 2007 and January 2017. The primary objective of the study was to evaluate overall survival (OS) in Mexican patients with APL. Secondary objective was to evaluate the impact of induction treatment with different anthracyclines on OS, event-free survival (EFS) and complications in this patient population.Methods
The medical charts of patients referred to medical institutions in Mexico from January 2007 through January 2017 for the treatment of suspected APL were reviewed retrospectively. Patients aged 15 - 75 years, in whom the diagnosis of APL was confirmed, who had an Eastern Cooperative Group performance status of 0 - 2, and who were eligible for "],"journal":["Journal of hematology"],"pagination":["53-63"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8110230"],"repository":["biostudies-literature"],"pubmed_title":["Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico."],"pmcid":["PMC8110230"],"pubmed_authors":["Espinoza-Zamora R","Sosa-Espinoza A","Arana L","Solis-Poblano JC","Mijangos J","Alvarado-Ibarra M","Aguilar M","Lourdes EJL","Ramirez-Romero EF","Perez Zuniga JM","De la Pena JA","Cervera E","de Jesus Perez O","Manuel MS","Ceballos-Lopez A","Montano E","Ojeda-Tovar J","Gomez-Perdomo G","Morales-Adrian J","Zapata-Canto N","Gomez-Almaguer D","Alvarez-Vera JL","Herrera M","Hernandez-Ruiz E","Barrera E","Solis-Armenta R","Ramos-Penafiel C","Flores-Jimenez JA","Diaz-Vargas G","Guillermo VA","Espitia-Rios E","Cabrera-Garcia A","Demichelis R"],"additional_accession":[]},"is_claimable":false,"name":"Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico.","description":"Background
The present retrospective study reviewed acute promyelocytic leukemia (APL) cases recorded in Mexico between January 2007 and January 2017. The primary objective of the study was to evaluate overall survival (OS) in Mexican patients with APL. Secondary objective was to evaluate the impact of induction treatment with different anthracyclines on OS, event-free survival (EFS) and complications in this patient population.Methods
The medical charts of patients referred to medical institutions in Mexico from January 2007 through January 2017 for the treatment of suspected APL were reviewed retrospectively. Patients aged 15 - 75 years, in whom the diagnosis of APL was confirmed, who had an Eastern Cooperative Group performance status of 0 - 2, and who were eligible for ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Apr","modification":"2025-04-04T11:58:02.116Z","creation":"2022-02-10T10:53:35.391Z"},"accession":"S-EPMC8110230","cross_references":{"pubmed":["34007366"],"doi":["10.14740/jh773"]}}